PLx Pharma Lands $8,273,297 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9157c98c-0908-4cf3-b075-d69e43dfbafd&Preview=1 - Date
3/20/2013 - Company Name
PLx Pharma - Mailing Address
8285 El Rio Houston, TX 77054 - Company Description
PLx Pharma is a pharmaceutical company developing the next generation of non-steroidal anti-inflammatory agents (NSAIDs) that are safer on the gut. - Website
http://www.plxpharma.com - Transaction Type
Debt, Venture Equity - Transaction Amount
$8,273,297 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
